greeksoup/ stock research

BWX Technologies, Inc.: Q1 FY2026 earnings call

What management said about Q1 FY2026, from the documents filed with the SEC on 4 May 2026: press release. Guidance figures: 4 raised. The quarter’s numbers.

Key takeaways

  • Revenue rose 26% to $860.2 million: Consolidated revenue was $860.2 million, up $178.0 million or 26% from $682.3 million a year earlier. Government Operations rose 4% and Commercial Operations rose 121%. Source
  • Adjusted EBITDA rose 14%: Adjusted EBITDA was $148.0 million against $129.8 million a year earlier, an increase of 14%. Net income was $91.2 million, against $75.5 million. Source
  • EPS rose on operating income: Diluted GAAP EPS was $0.99 against $0.82, and non-GAAP EPS was $1.12 against $0.91. Management cited higher operating income, lower interest expense and a lower effective tax rate, partly offset by lower other income. Source
  • Operating cash flow rose 83%: Operating cash flow was $92.6 million against $50.7 million. Management attributed the growth to higher net income and improved working capital management. Source
  • Precision Components acquisition builds US capacity: Management described the PCG acquisition as the first step in establishing U.S.-based commercial nuclear manufacturing capacity. Source

“Given our strong first quarter results, robust backlog, and optimistic market outlook, we are raising our 2026 financial guidance,”

Rex D. Geveden, president and chief executive officer

Guidance

AreaPeriodFigureAgainst last quarter
Revenue Sourceyear ending December 31, 2026>$3,750Raised from ~$3,750
Adjusted EBITDA Sourceyear ending December 31, 2026$650 million-$665 millionRaised from $645 million-$660 million
Non-GAAP EPS Sourceyear ending December 31, 2026$4.60-$4.75Raised from $4.55-$4.70
Free cash flow Sourceyear ending December 31, 2026$315 million-$330 millionRaised from $305 million-$320 million

What changed from last quarter

  • Guidance raised: 2026 guidance was raised for revenue, adjusted EBITDA, non-GAAP EPS and free cash flow, compared with the guidance initiated in February 2026. Source
  • New: BWXT announced the acquisition of Precision Components Group, LLC, to establish a U.S. footprint for commercial nuclear component manufacturing. Source
  • New: The number of manufacturing facilities owned and operated rose to 17, from 15 in the prior release. Source

Results and growth drivers

  • Revenue rose 26% to $860.2 million: Consolidated revenue was $860.2 million, up $178.0 million or 26% from $682.3 million a year earlier. Government Operations rose 4% and Commercial Operations rose 121%. Source
  • Adjusted EBITDA rose 14%: Adjusted EBITDA was $148.0 million against $129.8 million a year earlier, an increase of 14%. Net income was $91.2 million, against $75.5 million. Source
  • EPS rose on operating income: Diluted GAAP EPS was $0.99 against $0.82, and non-GAAP EPS was $1.12 against $0.91. Management cited higher operating income, lower interest expense and a lower effective tax rate, partly offset by lower other income. Source
  • GAAP operating income rose 10%: GAAP operating income was $106.7 million against $96.6 million, an increase of 10%, with growth in both segments. Source

Segment and product line results

  • Commercial revenue rose 121%: Commercial Operations revenue was $283.6 million against $128.3 million. Growth came from commercial nuclear components, field services, fuel and fuel handling, medical sales, and the Kinectrics contribution. Source
  • Government revenue rose 4%: Government Operations revenue was $577.9 million against $555.3 million. Higher special materials processing revenue and naval reactors growth drove the increase. Source
  • Government operating income nearly flat: Government Operations operating income was $99.1 million against $97.7 million, up 1%. Management attributed the slight decrease in non-GAAP segment operating income to revenue mix on newer special materials projects. Source
  • Non-GAAP operating income rose 13%: Non-GAAP operating income was $121.5 million against $107.6 million. Growth in Commercial Operations was partly offset by a modest decline in Government Operations and higher corporate expense. Source

“Investment in global nuclear markets is accelerating and demand for BWXT’s innovative nuclear solutions is growing rapidly,”

Rex D. Geveden, president and chief executive officer

Costs, adjustments and tax rate

  • Non-GAAP add-backs to operating income: Non-GAAP adjustments added $7.3 million of restructuring and transformation costs, $5.0 million of acquisition-related costs and $2.5 million of acquisition-related amortization to GAAP operating income. Source
  • Corporate expense increased: Unallocated corporate expense was $16.5 million on a GAAP basis, against $7.6 million a year earlier. On a non-GAAP basis it was $7.9 million, against $2.9 million. Source
  • Effective tax rate fell: The effective tax rate was 15.0% on a GAAP basis and 15.8% on a non-GAAP basis, against 17.7% and 18.3% a year earlier. Source

Backlog and bookings

  • Backlog at year-end 2025 was $7.3 billion: The prior release reported year-end 2025 backlog of $7.3 billion, up 50% year over year, driven by naval propulsion, special materials and commercial nuclear power awards.

“we are committed to strategically deploying capital, both organically and inorganically, to bolster our industrial scale to meet the needs of these exciting markets and drive value creation for our shareholders.”

Rex D. Geveden, president and chief executive officer

Cash flow, capital spending and dividends

  • Operating cash flow rose 83%: Operating cash flow was $92.6 million against $50.7 million. Management attributed the growth to higher net income and improved working capital management. Source
  • Capital spending rose on project timing: Capital expenditures were $42.5 million against $33.4 million, up 27%. Free cash flow was $50.1 million against $17.3 million. Management attributed the rise to timing of growth projects. Source
  • Dividend paid, no buybacks in quarter: BWXT paid $25.8 million in dividends in the quarter, with no common stock repurchases, against $30.0 million of repurchases a year earlier. Source

Strategy and nuclear market investment

  • Precision Components acquisition builds US capacity: Management described the PCG acquisition as the first step in establishing U.S.-based commercial nuclear manufacturing capacity. Source
  • Acquisition excluded from 2026 guidance: The 2026 guidance does not include any contribution from the PCG acquisition. Source
  • Pursuing new opportunities across three markets: Management said BWXT pursued new work across global security, commercial power and nuclear medicine markets during the quarter. Source

Coming up, as management said on 4 May 2026

  • Quarterly dividend payable June 5: The Board declared a $0.27 quarterly dividend on April 29, 2026, payable June 5, 2026 to holders of record on May 19, 2026. Source

Risks management discussed

  • Demand: Lower microreactor volumes partly offset the Government Operations revenue increase in the quarter. Source
  • Operational: Higher restructuring, transformation and acquisition-related costs weighed on GAAP operating income in the quarter. Source

Other quarters

Summarised with AI from the documents the company filed with the SEC. Every point is checked against the filing before it is shown: management’s own words word for word, figures against the line or table row they come from. A point that fails the check is left out. Source opens the filing at that line.